Drugs.com
MAY 1, 2025
THURSDAY, May 1, 2025 -- The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found.Nearly twice as many people taking semaglutide stopped their fatty liver disease without further.
Science Daily: Pharmacology News
MAY 1, 2025
Animal research on biomusicality, which looks at whether different species are capable of behaving in ways that show they recognize aspects of music, including rhythm and beat, remains a tantalizing field at the intersection of biology and psychology. Now, the highly trained California sea lion who achieved global fame for her ability to bob her head to a beat is finally back: starring in a new study that shows her rhythm is just as precise -- if not better -- than humans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Drive: Drug Pricing
MAY 2, 2025
Sales of the company’s copycat to J&J’s blockbuster medicine reached $150 million in the first quarter, adding to a surge in revenue for Amgen's biosimilar business.
Drug Target Review
APRIL 30, 2025
In the rapidly evolving field of cell and gene therapy (CGT), the ability to manage complex biological data, optimise manufacturing processes, and accelerate drug discovery is crucial. At the forefront of this revolution stands Claudia Zylberberg, a scientist, entrepreneur, and advocate for accessible and advanced healthcare solutions. Zylberberg has built an impressive career at the intersection of science, technology, and business.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drugs.com
MAY 2, 2025
FRIDAY, May 2, 2025 -- The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called "Generation Gold Standard" to develop next-generation, universal vaccines using a beta-propiolactone.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
MAY 1, 2025
The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core therapeutic areas” and “high value” programs.
Perficient: Drug Development
APRIL 30, 2025
Were proud to share that Perficient has been honored with a Globee Gold Award for Customer Excellence: Achievement in Customer Success Story, a global recognition celebrating organizations, teams, and individuals who consistently deliver exceptional customer experiences and drive innovation across industries. This award recognizes our significant success for a multinational manufacturing client.
Drugs.com
APRIL 30, 2025
WEDNESDAY, April 30, 2025 — More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was.
Science Daily: Pharmacology News
APRIL 29, 2025
Scientists believe they have found a way to improve warning systems for vulnerable communities threatened by humid heatwaves, which are on the rise due to climate change and can be damaging and even fatal to human health. The study analysed how patterns of recent rainfall can interact with dry or moist land conditions to influence the risk of extreme humid heat in the global tropics and subtropics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
APRIL 28, 2025
Pharmaceutical companies are turning to integrated RWD approaches to overcome challenges in rare disease research.
Conversations in Drug Development Trends
APRIL 29, 2025
On the last day of February every year is Rare Disease Day , a dedicated day to celebrate the rare disease community, including patients, families, caregivers, clinicians, researchers, regulators, and more. The day inspires multiple events, such as fundraisers and scientific symposia, to bring together all the critical stakeholders who tirelessly work to make life better for those affected by rare diseases.
Drugs.com
APRIL 30, 2025
WEDNESDAY, April 30, 2025 — Milwaukee will temporarily close two more elementary schools as it works to tackle a lead crisis in its public school buildings. The school district announced Monday that Westside Academy and Brown Street School.
Science Daily: Pharmacology News
APRIL 28, 2025
Researchers have developed a new catalyst design capable of pushing the projected fuel cell catalyst lifespans to 200,000 hours. The research marks a significant step toward the widespread adoption of fuel cell technology in heavy-duty vehicles, such as long-haul tractor trailers. While platinum-alloy catalysts have historically delivered superior chemical reactions, the alloying elements leach out over time, diminishing catalytic performance.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioPharma Drive: Drug Pricing
MAY 2, 2025
The FDA pushed back its decision date on Cytokinetics’ heart drug, while AstraZeneca got Phase 3 results that could help it expand use of a top drug.
Drug Patent Watch
APRIL 30, 2025
"Game Changers in Generic Drug Development: What's Next? As the pharmaceutical industry continues to evolve, one thing is clear: the future of generic drug development is about to get a whole lot more interesting. I recently came across an article that caught my eye: "The Future of Generic Drug Development: Emerging Technologies and Approaches" from @DrugPatentWatch.
Drugs.com
APRIL 28, 2025
MONDAY, April 28, 2025 -- Colon cancer cases have been increasing among younger adults, and now researchers think theyve identified a potential culprit.A bacterial toxin called colibactin, produced by certain strains of E. coli, appears to alter g.
Science Daily: Pharmacology News
APRIL 30, 2025
An increase in physical activity between the ages of 45 and 65 could help prevent Alzheimer's disease, while inactivity may be detrimental to brain health.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
MAY 1, 2025
The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on Thursday.
Drugs.com
APRIL 28, 2025
MONDAY, April 28, 2025 -- As case numbers rise, public health officials are warning of yet another difficult year of battling pertussis infections, according to a report from the Associated Press.Pertussis, commonly known as whooping cough, is.
Science Daily: Pharmacology News
APRIL 30, 2025
An experiment seven years in the making has uncovered new insights into the nature of consciousness and challenges two prominent, competing scientific theories: Integrated Information Theory (IIT) and Global Neuronal Workspace Theory (GNWT). The findings mark a pivotal moment in the goal to understand the elusive origins consciousness.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
BioPharma Drive: Drug Pricing
MAY 1, 2025
Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.
Perficient: Drug Development
APRIL 29, 2025
Sitecore Connect is Sitecore’s low-code integration platform designed to easily automate workflows between Sitecore and external systems, without heavy custom coding. If you’re new to Sitecore Connect or want a deeper understanding of when and how to use it, check out these helpful resources: When to Choose Sitecore Connect: Solving Integration Challenges Understanding Sitecore Connect: Building Integrations with Recipes In this practical example, we’ll demonstrate how to use S
Drugs.com
APRIL 29, 2025
TUESDAY, April 29, 2025 The push to remove artificial colors from U.S. foods is gaining speed, but making the change won't be easy or quick.Last week, U.S. health officials directed food companies to voluntarily phase out petroleum-based syn.
Science Daily: Pharmacology News
APRIL 30, 2025
Semaglutide effectively treats liver disease in two thirds of patients, new research has found.
BioPharma Drive: Drug Pricing
APRIL 29, 2025
The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.
Fierce BioTech
APRIL 30, 2025
Maximizing Brand Revenue: A Smarter Approach to Lifecycle Management This white paper introduces a smarter, more sustainable lifecycle management model. Instead of relying solely on promotion, forward-thinking commercial teams are prioritizing prescribing support and reallocating resources to remove friction across the entire product lifecycle. sdees Wed, 04/30/2025 - 11:55 This white paper introduces a smarter, more sustainable lifecycle management model.
Drugs.com
MAY 1, 2025
THURSDAY, May 1, 2025 Billionaire and Tesla CEO Elon Musk has made headlines with dire warnings that declining birth rates are an existential crisis for humanity.The threat might be even more dire than Musk (the father of at least 14) says, a ne.
Science Daily: Pharmacology News
APRIL 30, 2025
Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But some individuals, known as 'post-treatment controllers,' are able to maintain an undetectable viral load even after stopping treatment. Scientists have now identified specific immunogenetic characteristics in a group of these individuals.
Expert insights. Personalized for you.
277 
Let's personalize your content